Skip to main content
SpringerLink
Log in

Antithrombotic therapy in chronic leg arterial disease

  • Conference paper
Critical Limb Ischemia

  • 59 Accesses

Abstract

The natural history of atherosclerotic disease of the arteries of the leg is characterized by a relatively benign local clinical evolution. Even though the underlying atherosclerotic disease progresses with time, about three out of four men who present intermittent claudication will never require vascular reconstruction and less than 4% will require a major amputation (13).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Antiplatelet Trialists’ Collaboration (1988) Secondary prevention of vascular disease by prolonged antiplatelet treatment. Brit Med J 296: 320–333

    Google Scholar 

  2. Antiplatelet Trialists’ Collaboration (1994a) Collaborative Overview of Randomized Trials of Antiplatelet Treatment. Part I: Prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients. Brit Med J 308: 81–106

    Google Scholar 

  3. Antiplatelet Trialists’ Collaboration (1994b) Collaborative Overview of Randomized Trials of Antiplatelet Treatment. Part II. Maintenance of vascular graft or arterial patency by antiplatelet therapy. Brit Med J 308: 159–168

    Google Scholar 

  4. Arcan JC, Panak E (1989) Ticlopidine in the treatment of peripheral occlusive arterial disease. Seminars in Thrombosis and Haemostasis 15: 167–170

    Article  CAS  Google Scholar 

  5. Balsano F, Coccheri S, Libretti A, Nenci GG, Catalano M et al (1989) Ticlopidine in the treatment of intermittent claudication: a 21-month double blind trial. Journal of Laboratory and Clinical Medicine 114: 84–91

    PubMed  CAS  Google Scholar 

  6. Boissel JP, Peyrieux JC, Destors JM (1989) Is it possible to reduce the risk of cardiovascular events in subjects suffering from intermittent claudication of the lower limbs? Thrombosis and Haemostasis 62: 681–685

    PubMed  CAS  Google Scholar 

  7. Bollinger A, Brunner U (1985) Antiplatelet drugs improve the patency rates after femoropopliteal endarterectomy. Vasa 14: 272–279

    PubMed  CAS  Google Scholar 

  8. Clagett GP, Genton E, Salzman EW (1989) Antithrombotic therapy in peripheral vascular disease. Chest 95: 128S–139S

    PubMed  CAS  Google Scholar 

  9. Clagett GP, Graor RA, Salzman EW (1992) Antithrombotic therapy in peripheral arterial occlusive disease. Chest 102 Suppl 516S–528S

    Google Scholar 

  10. Clyne CAC, Archer TJ, Atuhaire LK, Chant ADB, Webster JHH (1987) Random control trial of a short course of aspirin and dipyridamole ( Persantin) for femorodistal grafts. British Journal of Surgery 74: 246–248

    Google Scholar 

  11. Criqui MH, Langer RD, Fronek A, Feigelson HS, Klauber MR et al (1992) Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 326: 381–386

    Article  PubMed  CAS  Google Scholar 

  12. de Smit P, Van Urk H (1987) The effect of long-term treatment with oral anticoagulants in patients with peripheral vascular disease. In: Tilsner V, Matthias FR (eds) Arterielle Verschlußkrankheit und Blutgerinnung. Editions ‘Roche’, p 211–217

    Google Scholar 

  13. Dormandy J, Mahir M, Ascädy G, Balsano F, De Leeuw P et al (1989) Fate of the patient with chronic leg ischemia. A review article. Journal of Cardiovascular Surgery 30: 55–57

    Google Scholar 

  14. Genton E, Clagett GP, Salzman EW (1986) Antithrombotic therapy in peripheral vascular disease. Archives of Internal Medicine 146: 470–471

    Google Scholar 

  15. Goldman M, McCollum C (1984) A prospective randomized study to examine the effect of aspirin plus dipyridamole on the patency of prosthetic femoropopliteal grafts. Vascular Surgery 18: 271–221

    Google Scholar 

  16. Green RM, Roederscheimer R, De Weese JA (1982) Effects of aspirin and dipyridamole on expanded polytetrafluoroethylene graft patency. Surgery 82: 1016–1026

    Google Scholar 

  17. Hamming J J, Hensen A, Loeliger EA (1965) The value of long-term coumarin treatment in peripheral sclerosis. Clinical trial (abstr.). Thromb Diath Haemorrh 21: 405

    Google Scholar 

  18. Hess H, Mietaschk A, Deichsel G (1985) Drug-induced inhibition of platelet function delays progression of peripheral occlusive arterial disease. A prospective double-blind arteriographically controlled trial. Lancet 1: 415–419

    Google Scholar 

  19. Janzon L, Bergqvist D, Boberg J, Boberg M, Eriksson I et al (1990) Prevention of myocardial infarction and stroke in patients with intermittent claudication; effects of ticlopidine. Results from STIMS, the Swedish Ticlopidine Multicentre Study. Journal of Internal Medicine 227: 301–308

    Google Scholar 

  20. Kohler TR, Kaufman JL, Kacoyanis G, Clowes A, Donaldson MC et al (1984) Effect of aspirin and dipyridamole on the patency of lower extremity bypass grafts. Surgery 96: 462–466

    PubMed  CAS  Google Scholar 

  21. Kretschmer G, Herbst F, Prager M, Sautner T, Wenzl E et al (1992) A decade of oral anticoagulant treatment to maintain autologous vein grafts for femoropopliteal atherosclerosis. Arch Surg 127: 1112–1115

    Article  PubMed  CAS  Google Scholar 

  22. McCollum C, Alexander C, Kenchington G et al (1991) Antiplatelet drugs in femoropopliteal vein bypasses: a multicenter trial. J Vase Surg 13: 150–162

    Article  CAS  Google Scholar 

  23. Ögren M, Hedblad B, Isacsson SO, Janzon L, Jungquist G, Lindell SE (1993) Noninvasively detected carotid stenosis and ischaemic heart disease in men with leg arteriosclerosis. Lancet 342: 1138–1141

    Article  PubMed  Google Scholar 

  24. Palareti G, Poggi M, Torricelli P, Balestra V, Coccheri S (1988) Long-term effects of ticlopidine on fibrinogen and haemorheology in patients with peripheral arterial disease. Thrombosis Research 52: 621–629

    Article  PubMed  CAS  Google Scholar 

  25. Prevention of Atherosclerotic Complications with Ketanserin Trial Group. Prevention of atherosclerotic complications: controlled trial with ketanserin (1989) British Medical Journal 298:424–430

    Google Scholar 

  26. Schoop W, Levy H, Schoop B, Gaentsch A (1983) Experimentelle und klinische Studien zu der sekundären Prävention der peripheren Arteriosklerose. In: Bollinger A, Rhyner K (eds) Thrombozytenfunktionshemmer, Georg Thieme Verlag, Stuttgart, pp 49–58

    Google Scholar 

  27. Stiegler H, Hess H, Mietaschk A, Tramppisch HJ, Ingrisch H (1984) Einfluß von Ticlopidin auf die periphere obliterierende Arteriopathie. Deutsche Medizinische Wochenschrift 109: 1240–1243

    Article  PubMed  CAS  Google Scholar 

  28. Verhaeghe R, Bounameaux H (1991) Peripheral arterial occlusion: thromboembolism and antithrombotic therapy. In Fuster V, Verstraete M (eds) Thrombosis in Cardiovascular Diseases. W.B. Saunders Company, Orlando, pp 423–449

    Google Scholar 

  29. Zeitler E, Reichold J, Schoop W, Loew D (1973) Einfluß von Acetylsalicylsäure auf das Frühergebnis nach perkutaner Rekanalisation obliterierter Arterien mit der Kathetermethode. Deutsche Medizinische Wochenschrift 98: 1285–1288

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Center for Molecular and Vascular Biology, University of Leuven, Campus Gasthuisberg Herestraat 49, 3000, Leuven, Belgium

    R. Verhaeghe

Authors
  1. R. Verhaeghe
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinik für Allgemeinchirurgie — Gefäßchirurgie und Traumatologie, Krankenhaus Porz am Rhein Akademisches Lehrkrankenhaus der Universität zu Köln, Urbacher Weg 19, 51149, Köln, Germany

    Svante Horsch  & Luc Claeys  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Dr. Dietrich Steinkopff Verlag GmbH & Co. KG, Darmstadt

About this paper

Cite this paper

Verhaeghe, R. (1995). Antithrombotic therapy in chronic leg arterial disease. In: Horsch, S., Claeys, L. (eds) Critical Limb Ischemia. Steinkopff. https://doi.org/10.1007/978-3-642-72515-9_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-72515-9_6

  • Publisher Name: Steinkopff

  • Print ISBN: 978-3-7985-0968-9

  • Online ISBN: 978-3-642-72515-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation